Fosun On Course To Full Indian Clearance For Gland Buyout

After several rounds of deferral, an Indian investment board has approved Fosun’s acquisition of Gland Pharma, clearing the way for the first Chinese mega acquisition in the Indian pharmaceutical space, although the deal is still expected to require the go ahead from a Cabinet committee on economic affairs.